This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Miller, G. G. Articles by Pierson, R. N. Search for Related Content PubMed PubMed Citation Articles by Miller, G. G. Articles by Pierson, R. N. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Heart Diseases Heart Transplantation

(Circulation. 1999;100:2396.)
© 1999 American Heart Association, Inc.

Brief Rapid Communications

Longitudinal Analysis of Fibroblast Growth Factor Expression After Transplantation and Association With Severity of Cardiac Allograft Vasculopathy

Geraldine G. Miller, MD; Stacy F. Davis, MD; James B. Atkinson, MD; Donald B. Chomsky, MD; Pedro Pedroso, BS; V. Seenu Reddy, MD; Davis C. Drinkwater, MD; Xiao-Ming Zhao, MD; Richard N. Pierson, MD

From the Departments of Medicine (G.G.M., S.F.D., D.B.C., P.P., X.-M.Z.), Pathology (J.B.A.), and Surgery (V.S.R., D.C.D., R.N.P.), Vanderbilt University Medical School, Nashville, Tenn. Dr Zhao is now at the Division of Cardiology, Brigham and Women’s Hospital, Boston, Mass.

Correspondence to Geraldine Miller, MD, A3310 Medical Center North, Vanderbilt University Medical School, Nashville, TN 37232-2605. E-mail geraldine.miller{at}mcmail.vanderbilt.edu

Background—Vascular smooth muscle cell growth factors are postulated to contribute to cardiac allograft vasculopathy (CAV). Few data quantitatively address the timing, location, or stimuli for growth factor expression and relationship to CAV.

Methods and Results—Acidic fibroblast growth factor (aFGF) mRNA expression was determined in serial endomyocardial biopsies during the first year after transplantation. Patients with high levels of aFGF mRNA and elevations after the early posttransplant period had significantly more severe CAV than patients with low aFGF and no late elevations.

Conclusions—Parenchymal aFGF expression varies between patients and in the same patient over time and correlates with development of CAV.

Key Words: surgery • transplantation • growth substances • circulation • genes • muscle, smooth

This article has been cited by other articles:

				W. Luo, A. Liu, Y. Chen, H. M. Lim, J. Marshall-Neff, J. H. Black, W. Baldwin III, R. H. Hruban, S. C. Stevenson, P. Mouton, et al. Inhibition of Accelerated Graft Arteriosclerosis by Gene Transfer of Soluble Fibroblast Growth Factor Receptor-1 in Rat Aortic Transplants Arterioscler. Thromb. Vasc. Biol., June 1, 2004; 24(6): 1081 - 1086. [Abstract] [Full Text] [PDF]

				D. M. Kilkenny, J. V. Rocheleau, J. Price, M. B. Reich, and G. G. Miller c-Src Regulation of Fibroblast Growth Factor-induced Proliferation in Murine Embryonic Fibroblasts J. Biol. Chem., May 2, 2003; 278(19): 17448 - 17454. [Abstract] [Full Text] [PDF]

				M. V. Autieri, S. Kelemen, B. A. Thomas, E. D. Feller, B. I. Goldman, and H. J. Eisen Allograft Inflammatory Factor-1 Expression Correlates With Cardiac Rejection and Development of Cardiac Allograft Vasculopathy Circulation, October 22, 2002; 106(17): 2218 - 2223. [Abstract] [Full Text] [PDF]

				D. X.-M. Zhao, Y. Hu, G. G. Miller, A. D. Luster, R. N. Mitchell, and P. Libby Differential Expression of the IFN-{gamma}-Inducible CXCR3-Binding Chemokines, IFN-Inducible Protein 10, Monokine Induced by IFN, and IFN-Inducible T Cell {alpha} Chemoattractant in Human Cardiac Allografts: Association with Cardiac Allograft Vasculopathy and Acute Rejection J. Immunol., August 1, 2002; 169(3): 1556 - 1560. [Abstract] [Full Text] [PDF]

				X.-M. Zhao, Y. Hu, G. G. Miller, R. N. Mitchell, and P. Libby Association of Thrombospondin-1 and Cardiac Allograft Vasculopathy in Human Cardiac Allografts Circulation, January 30, 2001; 103(4): 525 - 531. [Abstract] [Full Text] [PDF]